[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI830378A0 - Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendning laekemedel - Google Patents

Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendning laekemedel

Info

Publication number
FI830378A0
FI830378A0 FI830378A FI830378A FI830378A0 FI 830378 A0 FI830378 A0 FI 830378A0 FI 830378 A FI830378 A FI 830378A FI 830378 A FI830378 A FI 830378A FI 830378 A0 FI830378 A0 FI 830378A0
Authority
FI
Finland
Prior art keywords
deras
tiaziner
pyrazoloxaziner
kinoliner
laekemedel
Prior art date
Application number
FI830378A
Other languages
English (en)
Other versions
FI830378L (fi
Inventor
Rudolf Sundermann
Harald Horstmann
Siegfried Raddatz
Mithat Mardin
Wolf-Dieter Busse
Friedrich Hoffmeister
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI830378A0 publication Critical patent/FI830378A0/fi
Publication of FI830378L publication Critical patent/FI830378L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI830378A 1982-02-06 1983-02-03 Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel FI830378L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FI830378A0 true FI830378A0 (fi) 1983-02-03
FI830378L FI830378L (fi) 1983-08-07

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830378A FI830378L (fi) 1982-02-06 1983-02-03 Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel

Country Status (16)

Country Link
US (1) US4552874A (fi)
EP (1) EP0085881A3 (fi)
JP (1) JPS58146583A (fi)
KR (1) KR840003641A (fi)
AU (1) AU1112583A (fi)
DE (1) DE3204126A1 (fi)
DK (1) DK49283A (fi)
ES (1) ES519559A0 (fi)
FI (1) FI830378L (fi)
GR (1) GR77960B (fi)
HU (1) HU190063B (fi)
IE (1) IE830227L (fi)
IL (1) IL67826A0 (fi)
NO (1) NO830236L (fi)
PT (1) PT76147A (fi)
ZA (1) ZA83743B (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
ES537162A0 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
EP0913395A1 (en) * 1995-12-08 1999-05-06 Ube Industries, Ltd. N-phenylcarbamate compounds, process for producing the same, and agricultural or horticultural bactericides
TW200524927A (en) 2003-08-12 2005-08-01 3M Innovative Properties Co Hydroxylamine substituted imidazo-containing compounds
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
ES2392647T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos tetracíclicos quirales que inducen la biosíntesis de interferón
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US7872002B2 (en) * 2007-06-08 2011-01-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline derivatives
CA2688405A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
KR20100036306A (ko) * 2007-06-08 2010-04-07 헬리콘 테라퓨틱스 인코퍼레이티드 치료용 피라졸로나프티리딘 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4891096A (fi) * 1972-03-08 1973-11-27
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
IL67826A0 (en) 1983-06-15
DK49283D0 (da) 1983-02-04
KR840003641A (ko) 1984-09-15
AU1112583A (en) 1983-08-11
US4552874A (en) 1985-11-12
ES8402591A1 (es) 1984-02-01
PT76147A (en) 1983-02-01
JPS58146583A (ja) 1983-09-01
HU190063B (en) 1986-08-28
IE830227L (en) 1983-08-06
ZA83743B (en) 1983-11-30
NO830236L (no) 1983-08-08
EP0085881A2 (de) 1983-08-17
DK49283A (da) 1983-08-07
DE3204126A1 (de) 1983-08-11
FI830378L (fi) 1983-08-07
GR77960B (fi) 1984-09-25
EP0085881A3 (de) 1984-03-07
ES519559A0 (es) 1984-02-01

Similar Documents

Publication Publication Date Title
FI830752A0 (fi) Karboxialkyldipeptider, foerfaranden foer deras framstaellning och farmaceutiska blandningar innehaollande dessa
FI831591A0 (fi) Azolylmetyloxiraner, deras framstaellningsfoerfarande och dessa innehaollande fungicider
FI830378A0 (fi) Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendning laekemedel
FI842601A0 (fi) Utdelningsanordning och uppteckningsapparat.
FI834430A (fi) Haorfaergningsfoerfarande och faergningskompositionsfoerpackning.
FI833398A (fi) Termiticidala atraktantfoereningar, kompositioner och foerfarande foer deras anvaendning
FI834888A0 (fi) Gonadoliberinderivat, foerfarande foer deras framstaellning och farmaceutiska och veterinaermedicinblandningar framstaellda daerav
FI834452A (fi) Aromatiska oligomerer och hartser.
FI824126L (fi) Foerfarande i laonghaolbergborrning och borrstaongsystem.
FI833857A (fi) Jaemn och med roterande skiva foersedd trycksil foer en medelkonsistens.
FI830457L (fi) Laosanordning, speciellt foer laemmar till lastflak och dylikt
FI833390A (fi) Utmatningsanordning med bortsvepningsoeppningar och utmatningsfoerfarande.
FI842376A (fi) Monoskopisk och stereoskopisk televisionsapparat.
FI831790A0 (fi) Piperazinderivat, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI831367A0 (fi) Pleuromutillinderivat, deras framstaellningsfoerfarande och farmaceutiska anvaendning
FI830297A0 (fi) Benzotiennylallylaminer, foerfarande foer deras producering och deras anvaendning saosom laekemedel
FI832789A (fi) Mjoeldrygealkaloider, deras framstaellning och anvaendning
FI833292A (fi) Piperidinderivat, deras framstaellning och anvaendning
FI833337A0 (fi) Heterocykliska foereningar, deras framstaellning, dessa innehaollande kompositioner och foerfarandekontrollering av ooenskad tillvaext av vaexter
FI833102A (fi) Substituerade 1-pyridyloxi-3-indolylalkyl-amino-2-propanoler, deras framstaellning och anvaendning
FI830206A0 (fi) Roterande, gaengfoersedd borrande och gaengbildande skruv
FI830992A0 (fi) 7- -aminoacyl-3-klorkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning solaekemedel
FI821506L (fi) Saekerhetskoppling foer baotar, motorslaedar och liknande
FI823970A0 (fi) Slaeptaetningsmontering foer foenster och motsvarande oeppningsbara byggnadsdelar, baoge och taetninmontering
FI882004A0 (fi) Substituerade nitro- och cyanoguanidiner och framstaellning daerav.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT